Jeffrey Thomas Elliott is CFO at EXACT SCIENCES CORP (EXAS). They have made 27 open-market trades across 1 company since 2017, most recently 2026-08-19.
CIK 0001689757
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 27 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXAS | SELL · 10b5-1 | 2024-05-01 | 2024-05-02 | $60.15 | $8K | -13.6% | -28.3% | -26.9% |
| EXAS | SELL · 10b5-1 | 2024-03-01 | 2024-03-04 | $59.32 | $286K | +0.1% | +24.5% | -23.4% |
| EXAS | SELL · 10b5-1 | 2024-02-27 | 2024-02-28 | $56.89 | $308K | +6.4% | +23.4% | -17.6% |
| EXAS | SELL · 10b5-1 | 2024-02-22 | 2024-02-23 | $59.78 | $162K | -1.3% | +11.8% | -5.2% |
| EXAS | SELL · 10b5-1 | 2024-02-21 | 2024-02-22 | $61.50 | $184K | -2.1% | +6.7% | -10.5% |
| EXAS | SELL · 10b5-1 | 2024-02-15 | 2024-02-16 | $61.43 | $232K | -4.1% | -1.9% | -13.4% |
| EXAS | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $82.92 | $5.0M | -2.5% | -21.2% | -23.2% |
| EXAS | SELL | 2023-02-28 | 2023-03-01 | $61.12 | $517K | +3.6% | +10.6% | +32.3% |
| EXAS | SELL | 2023-02-22 | 2023-02-23 | $62.72 | $179K | +10.0% | +11.2% | +37.3% |
| EXAS | SELL | 2023-02-15 | 2023-02-16 | $65.59 | $245K | -0.1% | +1.5% | +25.8% |
| EXAS | SELL | 2023-02-13 | 2023-02-14 | $64.55 | $149K | -7.5% | +1.7% | +24.4% |
| EXAS | SELL | 2022-03-01 | 2022-03-02 | $76.69 | $621K | -22.5% | -0.2% | -34.2% |
| EXAS | SELL | 2022-02-24 | 2022-02-25 | $70.10 | $827K | -8.2% | -13.8% | -36.7% |
| EXAS | SELL | 2022-02-23 | 2022-02-24 | $69.05 | $215K | -4.8% | -9.9% | -35.7% |
| EXAS | SELL | 2022-02-15 | 2022-02-16 | $79.55 | $293K | -1.1% | -13.4% | -30.0% |
| EXAS | SELL | 2021-07-29 | 2021-08-03 | $111.40 | $8.5M | -10.3% | +4.9% | -5.9% |
| EXAS | SELL | 2021-03-03 | 2021-03-05 | $135.02 | $711K | +5.9% | +10.2% | -11.1% |
| EXAS | SELL | 2021-03-02 | 2021-03-03 | $139.24 | $1.2M | +2.5% | +5.8% | -14.3% |
| EXAS | SELL | 2021-03-01 | 2021-03-02 | $136.86 | $2.1M | -5.2% | -2.2% | -20.0% |
| EXAS | SELL | 2021-02-24 | 2021-02-25 | $136.30 | $1.2M | -4.7% | -7.9% | -16.2% |
| EXAS | SELL | 2021-02-17 | 2021-02-18 | $142.66 | $576K | -5.2% | -6.0% | -32.7% |
| EXAS | SELL | 2020-07-31 | 2020-08-04 | $93.81 | $7.0M | -7.9% | -17.6% | +31.5% |
| EXAS | SELL | 2020-07-29 | 2020-07-30 | $95.58 | $1.7M | -11.0% | -19.9% | +35.7% |
| EXAS | SELL | 2020-02-28 | 2020-03-02 | $80.17 | $382K | -33.5% | -27.9% | +10.2% |
| EXAS | SELL | 2020-02-27 | 2020-02-28 | $80.27 | $261K | -29.3% | -28.6% | +2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.